Endeau

Info

Contact John Lyon
Title CEO

Description

Endeau is developing enabling technology for the routine performance of Water Aided Endoscopy (WAE), an emerging technique in interventional and screening gastroenterology procedures. WAE promises to improve polyp detection rate, contribute to safer removal and to minimize the need for sedation. The US market for WAE equipment and devices is estimated to be $2.6 billion annually. We plan to commercialize the first products within two years, led by an experienced management team and clinical advisors with a global reputation.
Endeau is raising development funding of $1.5 million to finance the engineering and 510(k) regulatory approval of our initial enabling product line.